QCLS insider now holds 12,500 Q/C Technologies shares after RSU grant
Rhea-AI Filing Summary
Q/C Technologies, Inc. (QCLS) reported an equity award to one of its insiders. On 11/14/2025, a director and Chief Medical Officer acquired 11,420 shares of common stock through a grant of restricted stock units at a price of $0 per share, bringing their directly held beneficial ownership to 12,500 shares. The RSUs were originally granted on 10/03/2025, subject to stockholder approval of an amendment to the company’s 2021 Equity Incentive Plan. Stockholders approved this plan amendment on 11/14/2025, and the RSUs vested immediately upon issuance.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Q/C Technologies (QCLS) report on this Form 4?
Q/C Technologies reported that a director and Chief Medical Officer acquired 11,420 shares of common stock via a grant of restricted stock units on 11/14/2025.
What is the reporting person’s new share ownership in Q/C Technologies (QCLS)?
After the reported transaction, the insider beneficially owns 12,500 shares of Q/C Technologies common stock in direct ownership.
At what price were the Q/C Technologies (QCLS) RSUs granted?
The 11,420 restricted stock units reported on the Form 4 were acquired at a stated price of $0 per share.
When were the Q/C Technologies (QCLS) RSUs originally granted and when did they vest?
The RSUs were originally granted on 10/03/2025 and vested immediately upon issuance after stockholder approval on 11/14/2025.
What plan governs the RSU grant reported by Q/C Technologies (QCLS)?
The RSU grant was made under the Q/C Technologies, Inc. 2021 Equity Incentive Plan, as amended by a plan amendment approved by stockholders.
What conditional approval was required for the Q/C Technologies (QCLS) RSUs?
The RSUs were subject to stockholder approval of a Plan Amendment to the 2021 Equity Incentive Plan, which was approved on 11/14/2025.